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Background/Objective. Burn injury is a devastating injury. The economic drain on the patient’s purse is equally devastating. Few
studies have examined the cost of managing burn patients particularly the drug component. Methods. The ﬁnancial implication of
drug use in the management of 69 consecutive patients admitted by the burn unit over a period of two years was retrospectively
analysed. Results. Thirty-six (52.2%) patients were males and 33 (47.8%) females with a mean age of 17.9 years (SD = 18.4).
The patients spent an average sum of $91.21 to procure drugs; 84.3% of the costs were for antibiotics, 11.1% for analgesics, and
4.6% for others. Conclusion. Signiﬁcant amount of money is spent on the procurement of drugs. Most of the money is spent
on prescribed antibiotics. Measures that reduce antibiotics use in burn management might relief patients of the huge economic
burden associated with its use.
Copyright © 2009 Kolawole Olubunmi Ogundipe et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Burn injury is one of the most devastating injuries anyone
can sustain and remain alive. Masellis considered it to
be the most complex trauma which can strike a human
organism [1]. The mortality following burn injuries used to
be very high, but improvement in management has resulted
in increased survival of the burnt patient over the years
[2, 3]. This reduction in mortality has been attributed to
the establishments of burn centres and changes in burn
wound treatment policy [4]. With increasing survival comes
a huge economic drain on the patient’s pulse which is
comparable with the resultant dis ment, disability, and
emotional instability following the injury as the overall cost
of care of burnt patients is very high [5].
Studies have been conducted to support the need for
surgical interventions in decreasing the cost of care and to
show the proﬁtability of burn centres [6–8]. These studies
have shown that when burnt patients are managed in burn
centres where surgical interventions, namely early excision
and wound cover, are carried out, the length of hospital stay
is reduced signiﬁcantly. Few studies however have examined
the cost associated with burn patients’ care, still fewer
researches have reviewed the pattern of drug utilization and
the cost of the medications in the management of burns [9,
10]. This study was done to determine the pattern of drugs
utilization and cost of drugs in the management of patients
with acute burns in a tertiary hospital in a developing
country.
2. Patients andMethod
A retrospective analysis was conducted based on the case
reports of 69 consecutive patients that presented to the
accident and emergency (A and E) ward of our hospital,
a tertiary institution located in North Central region of
Nigeria, with acute burns and admitted by the plastic unit
from the 1st of April 2003 to the 31st of March 2005.
Their treatment sheets and drug charts were examined to
determine the types of drugs prescribed and administered,
their doses and duration of use. The age, sex, percentage
burnt surface area and depth, length of hospital stay, and
disposition were determined for each patient. The mode of
treatment, namely: conservative versus surgical intervention,2 Journal of Tropical Medicine
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Figure 1: Sex and age distribution of patients.
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Figure 2: Frequency of total burnt surface area and depth of burn.
as well as the types of dressings carried out was noted.
The medications used were classiﬁed into pharmacological
classes antibiotics, analgesics, sedatives, tetanus prophylaxis,
antacids and anti-ulcer regimen, and accessories for drug
administration (infusion giving sets, syringes and needles,
canulae, etc.) according to the national drug formulary. The
cost of the drugs was calculated in accordance with the
hospital pharmacyacquisitioncost[USD]of similar drugsin
recent time (2006). The medications that were administered
intheoperatingtheatreforpatientsthatunderwentoperative
procedures were excluded from the analysis. The results are
presented in simple tables and charts using the Microsoft
Excel 2003 Software.
3. Result
Of the 69 burn patients that were admitted during the period
under review, 36 (52.2%) were male and 33 (47.8%) were
females giving a male to female ratio of 1.1 : 1. Though
the mean age was 17.9 years with a standard deviation of
18.4years (range 1 month to 68 years), 30 (43.5%) of the
patients were less than 10 years old, and only 7 (10.1%) were
50 years and above (Figure 1). Twenty (29.0%), 17 (24.7%),
13 (18.8%), 4 (5.8%), 12 (17.4%) and 3 (4.3%) patients
had burns involving 0–9, 10–19, 20–29, 30–39, 40–49, 50
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Figure 3: Length of hospital stay.
and above percent burnt surface area (BSA) respectively
(Figure 2). The mean body surface area burnt was 21.5%.
The burns were partial thickness in 59 (85.5%) and full
thickness in 10 (14.5%) patients.
Figure 3showsthelengthofhospitalstay,withanaverage
stay of 15.4 days (range 1–74 days). Forty-four (63.8%)
patients were discharged while 18 (26.1%) died and 7
(10.1%) left against medical advice. Eight (44.4%) of the
deaths occur in less than 10 days of admission. Most of
the patients were managed conservatively. This involved the
application of topical dressings that were changed initially
daily and subsequently on alternate day or longer period as
dictated by the wound condition. The main materials used
for dressing include honey in 48 patients, sulfatulle or its
variants in 28 patients, dermazine (1% silver sulfadiazine) in
31 patients and antibiotic impregnated Vaseline gauze in 24
patients. Most of the patients actually had a combination of
the dressing materials used at various periods. The choice of
thedressingmaterialswaslargelydeterminedbythepatients’
clinical presentation as well as their ﬁnancial status. Some
forms of operative interventions, including escharotomies
and skin grafting, were performed in 7 (10.1%) patients.
The plastic surgery unit did not have a dedicated theatre
as at the time of management of the patients presented.
All patients presenting to the unit and requiring surgery
had to be operated on a single weekly list that was highly
competitive.Emergenciesalsohadtocompeteforthelimited
space available to all surgical specialities.
On an average the cost of management (dressings,
surgery, drugs, admission charges and nursing care) of a
patient was about $274.56 (range $87.92–1029.23). This
exclude indirect cost to the patients incurred on things like
transportation, feeding, as well as cost of disability, and work
dayslost.Table 1 illustratethecostincurredbythepatientsin
procuring the drugs administered. An average sum of $91.21
(witharangeof$13.42–420.86) wasspentperpatient; 84.3%
of the costs were for antibiotics, 11.1% for analgesics, and
4.6% for others. This also amount to an average sum of $5.92
per day of admission per patient (average length of hospital
stay is 15.4 days) and $4.25 per percent burnt surface area
(mean BSA 21.5%).
4. Discussion
The management of burn injuries still poses a serious chal-
lenge. Burn centres, where they are available have reducedJournal of Tropical Medicine 3
Table 1: Cost of drug use in management.
Prescribed group of drugs Average cost of acquisition
per patient ($
∗)
Range of drug acquisition
cost per patient ($
∗)
%o ft o t a lc o s tf o rd r u g s
Antibiotics 76.87 7.29–358.21 84.3
Analgesics 10.12 0.04–57.43 11.1
Sedatives 0.64 0–2.15 0.7
Tetanus prophylaxis 0.72 0.72 0.8
Anti-ulcer regime 0.70 0–4.80 0.8
Accessories 2.14 2.01–2.42 2.3
Total cost for all drugs 91.21 13.42–420.86 100.0
∗United State Dollar
the menace of the injury. Adigun and Abdulrahman [11]h a d
earlier stressed the need to create burn centres in Nigeria,
today a number of burn centres exist in the countries. We
still do not have a burn centre in our hospital though.
The almost equal gender distribution found in this study
is diﬀerent from the male predominance reported in other
studies within this country [12, 13]. Children below the age
of10yearsconstitute43.5%ofpatientsinthisstudy,followed
by the age range 10–19 years (18.8%). A similar study by
Olabanji et al. [14] also showed that 53% of the studied
patients were in their ﬁrst decade of life.
The mean TBSA of 21.5% obtained in this study was
low compared to two previous studies at Ibadan, Nigeria
where mean TBSA of 36% and 38% were obtained four years
apart [15]. This diﬀerence in mean TBSA might account for
the lower mortality rate of 26.1% obtained in this study as
against the mortality rate of 36% and 34% in the Ibadan
studies.Fifty(72.5%)patientssustainedburninjurylessthan
30% TBSA, 85.5% of which was partial thickness. This may
in a way be responsible for the 15.4 days average length of
hospital stay noted in this study.
As noted majority of the burns are <30% TBSA (<15.5%
of these full thickness) and mostly scald in paediatric age
group. Little wonder that very few patients had any operative
intervention. Most of these patients were managed by initial
debridement under conscious sedation followed by a course
ofantibiotics,analgesicandroutinedressings(usuallyhoney,
dermazine or antibiotics impregnated Vaseline gause). Some
of the patients that would have beneﬁted from split skin
grafts to enable early wound healing could not have the
procedure because of lack of fund. Limited theatre space
also contributed signiﬁcantly to the low rate of operative
intervention carried out. It is had to convince the theatre
staﬀ and fellow surgeons that a patient who sustained burn
requires emergency operation in the face of other general
surgical emergencies. This could only be reverted only when
there is a burn unit with its own theatre and dedicated staﬀ.
Studies had shown that early excision and skin grafting of
burn (and other operative interventions) not only reduces
mortality, but also reduces the length of hospital days and
invariably the cost of treatment [16–18]. Since reducing the
cost of injury without signiﬁcantly aﬀecting the quality of
care given is the utmost desire of health care practitioners,
burn practitioners should continue the campaign for the
establishment of burn centres in the practice. de Roche after
a study of the cost of burn care noted that the cost of care is
extremely high and concluded that any economic eﬀort for
primary burn treatment , however high it may be , is justiﬁed
ifthedurationofrehabilitationandinvaliditycanbereduced
[19].
Lofts in his study noted an expenditure of $647 per
patient per day or $927 per % burn for the total cost of
a successful inpatient management of a major burn [18].
Burn care is expensive to procure, and this much more so in
the developing countries where the average daily income per
personislessthan$1(GDPof$320perannual—WorldBank
Statistic2003),andhealthinsuranceschemewasalmostnon-
existent until recently. For a patient in such a poverty–ridden
country to spend between $87.92 and $1029.23on burn care
o na1 5 . 4d a ya v e r a g ei se x t r e m e l yh i g h .T h e r ei san e e dt o
lookinwardtowaysofmakingthecostofcarecheaperforthe
patients. To the best of our knowledge, drug procurement is
one the cheapest expenditure in the management of burn,
most expenses are spent of on dressings, admission and
nursingcharges,surgicalproceduresandothermiscellaneous
expenses. The drugs, most especially antibiotics, also ought
to be administered only when needed. In this study, on an
average, a whooping $91.21 (33.2% of average total cost of
care) was spent per patient in procuring drugs alone, this
translates to $5.92 per day of admission per patient or $4.25
per patient per percent burnt surface area. It should be noted
thatmostofthepatientsinthisstudywerechildren,meaning
that for an adult patient the cost spent could actually be
far above this as the dosing regime in adult is higher than
that in children. Most of the money (84.3%) was spent on
prescribed antibiotics. Even though the use of antibiotics
in burn management is controversial [20], usually we use a
course of a cephalosporin or quilonone and metronidazole
for our patients. Will it then be justiﬁable to withhold the
prescription of antibiotics in order to minimize this high
economic burden? Where well equipped burn centres with
easily accessible auxiliary services such as the laboratories
are available, a delay in the prescription of antibiotics may
be justiﬁed in as much as early diagnosis and management
of suspected infection are feasible. Though our centre is
a tertiary institution, we do not have a burn centre; our
patients could not readily provide ﬁnances for laboratory
investigation and surgical interventions, preventing and4 Journal of Tropical Medicine
monitoring for infection therefore become diﬃcult. Thus
one cannot shy away from the use of antibiotics if it remains
the sure way of ensuring survival of the patient. Further
studiesarehoweverneededtocomparethecostofantibiotics
use in the conservative setting we adopted with that incurred
when early surgical interventions are carried out. Regardless
of the ﬁnding, improved funding of patients’ care will ensure
that they get the appropriate treatment as at when due.
This will reduce the morbidities incurred (wound infection,
increased length of hospital stay, etc.) when treatments are
delayed.
5. Conclusion
Themoneyspentondrugsisenormouswhencomparedwith
our available income. In as much as the best treatment is the
cheapest, what chance then do we have as practitioners in the
developing countries to curtail the cost of care of our burn
patients! One cannot overemphasis the need for increased
funding such as the extension of health insurance scheme to
cover burn management. Few operative procedures were also
carried out in this study group mostly because the patients
could not aﬀord them, it is expected that when funds are
available for more operative interventions, the overall length
of hospital stay will reduce, with an attending reduction in
drug use and thus cost of money spent in their procurement.
A comprehensive analysis of the total cost of burn care will
also bring to the fore areas where cost may be curtailed
without aﬀecting the quality of the given care adversely.
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